DGAP-Adhoc: CompuGroup Medical acquires VISUS Health IT
DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Mergers & Acquisitions
CompuGroup Medical acquires VISUS Health IT
01-Jun-2021 / 15:14 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Koblenz, 1 June 2021 - Today, CGM Clinical Deutschland GmbH, a 100 % subsidiary of CompuGroup Medical SE & Co. KGaA ("Company"), and the German based VISUS Beteiligungsgesellschaft mbH and Grönemeyer Medical GmbH & Co. KG have entered into an agreement regarding the acquisition of 100 % of the shares in VISUS Health IT GmbH ("VISUS") based in Bochum, Germany. The competent corporate bodies of the Company have already approved the transaction.
VISUS develops and distributes solutions for Picture Archiving and Communication Systems (PACS) as well as Healthcare Content Management (HCM). With this transaction, the Company is expanding its offering into the radiology sector.
The transaction is structured as a share deal with a retrospective economic effective date as of the end of 2020. The cash purchase price for the shares in VISUS amount to approximately EUR 50 million. In the financial year 2020, VISUS generated revenues of approximately EUR 18.5 million and an adjusted EBITDA of approximately EUR 2.8 million.
The closing of the transaction will take place immediately after the conclusion of the agreement and is not subject to any closing conditions.
01-Jun-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
Language: |
English |
Company: |
CompuGroup Medical SE & Co. KGaA |
|
Maria Trost 21 |
|
56070 Koblenz |
|
Germany |
Phone: |
+49 (0)261 8000 7030 |
Fax: |
+49 (0)261 8000 3200 |
E-mail: |
[email protected] |
Internet: |
www.cgm.com |
ISIN: |
DE000A288904 |
WKN: |
A28890 |
Indices: |
MDAX, TecDAX |
Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: |
1203210 |
|
End of Announcement |
DGAP News Service |
1203210 01-Jun-2021 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
Umsatzerlöse1 |
582,38 |
717,02 |
745,81 |
837,26 |
1.025,32 |
1.129,74 |
1.187,66 |
EBITDA1,2 |
128,44 |
187,84 |
178,13 |
197,48 |
213,39 |
216,35 |
229,76 |
EBITDA-Marge3 |
22,05 |
26,20 |
23,88 |
23,59 |
20,81 |
19,15 |
|
EBIT1,4 |
90,07 |
143,23 |
115,27 |
121,77 |
102,68 |
104,03 |
113,96 |
EBIT-Marge5 |
15,47 |
19,98 |
15,46 |
14,54 |
10,01 |
9,21 |
9,60 |
Jahresüberschuss1 |
31,74 |
96,34 |
66,15 |
73,42 |
69,03 |
74,12 |
46,87 |
Netto-Marge6 |
5,45 |
13,44 |
8,87 |
8,77 |
6,73 |
6,56 |
3,95 |
Cashflow1,7 |
85,82 |
136,35 |
110,50 |
149,93 |
165,27 |
145,03 |
179,53 |
Ergebnis je Aktie8 |
0,63 |
1,92 |
1,33 |
1,40 |
1,30 |
1,40 |
0,88 |
Dividende8 |
0,35 |
0,50 |
0,50 |
0,50 |
0,50 |
0,50 |
0,35 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: KPMG
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
CompuGroup Medical |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
A28890 |
29,100 |
Halten |
1.563,68 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
22,38 |
35,85 |
0,63 |
24,98 |
KBV |
KCV |
KUV |
EV/EBITDA |
2,54 |
8,71 |
1,32 |
9,76 |
Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e in % |
Hauptversammlung |
0,50 |
1,00 |
3,44 |
22.05.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
08.05.2024 |
08.08.2024 |
07.11.2024 |
28.03.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
-4,81% |
-20,20% |
-23,22% |
-41,02% |
|
|